Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-03 · accession 0000950170-25-002052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-06 | 2025-01-03 | AXSM | Coleman Mark | Dir | M - OptEx | $9.00 | +9,127 | 57.1K | +19% | +$82.1K |
| D | 2025-01-06 | 2025-01-03 | AXSM | Coleman Mark | Dir | M - OptEx | $0.00 | -9,127 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-03 | M | A | 9,127 | $9.00 | 57,137 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-01-03 | M | D | 9,127 | $0.00 | 0 | D | $9.00 · 2016-11-19 to 2025-11-19 | 9,127 Common Stock |